KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Depreciation & Amortization (CF) (2016 - 2026)

National Health Investors filings provide 17 years of Depreciation & Amortization (CF) readings, the most recent being $23.7 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 23.67% to $23.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $63.8 million, a 12.68% decrease, with the full-year FY2025 number at $80.9 million, up 13.3% from a year prior.
  • Depreciation & Amortization (CF) hit $23.7 million in Q1 2026 for National Health Investors, up from $20.2 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $23.7 million in Q1 2026 to a low of $17.1 million in Q4 2023.
  • Median Depreciation & Amortization (CF) over the past 5 years was $17.7 million (2023), compared with a mean of $18.5 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 13.97% in 2022 and later grew 23.67% in 2026.
  • National Health Investors' Depreciation & Amortization (CF) stood at $17.3 million in 2022, then dropped by 1.11% to $17.1 million in 2023, then grew by 9.17% to $18.7 million in 2024, then grew by 8.22% to $20.2 million in 2025, then grew by 17.19% to $23.7 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $23.7 million (Q1 2026), $20.2 million (Q3 2025), and $19.9 million (Q2 2025) per Business Quant data.